Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,775 | -2,852 | -1,134 | -619 | -743 |
| Depreciation Amortization | 73 | 62 | 50 | 66 | 166 |
| Accounts receivable | 21 | -202 | -23 | -1 | -41 |
| Accounts payable and accrued liabilities | 562 | 7 | 70 | -19 | -478 |
| Other Working Capital | 517 | -44 | 107 | -65 | 1,092 |
| Other Operating Activity | -512 | 320 | 217 | 62 | 519 |
| Operating Cash Flow | $-2,113 | $-2,709 | $-712 | $-576 | $515 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -47 | -106 | -36 | 4 | -66 |
| Investing Cash Flow | $-47 | $-106 | $-36 | $4 | $-66 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,200 | 2,750 | N/A | 231 | N/A |
| Common Stock Issued | 2 | N/A | 879 | N/A | N/A |
| Other Financing Activity | 0 | 2 | -198 | -5 | -706 |
| Financing Cash Flow | $2,202 | $2,752 | $681 | $226 | $-706 |
| Beginning Cash Position | 57 | 119 | 185 | 532 | 788 |
| End Cash Position | 99 | 57 | 119 | 185 | 532 |
| Net Cash Flow | $42 | $-62 | $-66 | $-347 | $-256 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,113 | -2,709 | -712 | -576 | 515 |
| Capital Expenditure | -47 | -106 | -36 | -15 | -66 |
| Free Cash Flow | -2,160 | -2,815 | -748 | -591 | 449 |